1sb1: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /> <applet load="1sb1" size="450" color="white" frame="true" align="right" spinBox="true" caption="1sb1, resolution 1.90Å" /> '''Novel Non-Covalent ...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1sb1.gif|left|200px]]<br />
[[Image:1sb1.gif|left|200px]]<br /><applet load="1sb1" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="1sb1" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="1sb1, resolution 1.90&Aring;" />
caption="1sb1, resolution 1.90&Aring;" />
'''Novel Non-Covalent Thrombin Inhibitors Incorporating P1 4,5,6,7-Tetrahydrobenzothiazole Arginine Side Chain Mimetics'''<br />
'''Novel Non-Covalent Thrombin Inhibitors Incorporating P1 4,5,6,7-Tetrahydrobenzothiazole Arginine Side Chain Mimetics'''<br />


==Overview==
==Overview==
The design, synthesis and biological activity of a series of novel, non-covalent D-Phe-Pro-Arg motif-based thrombin inhibitors incorporating, 4,5,6,7-tetrahydrobenzothiazol-2-amine as a novel arginine surrogate are, described. Compound 9, the most potent in the series of thrombin, inhibitors, exhibited an in vitro K(i) of 128 nM and 342-fold selectivity, against trypsin. The binding mode of this novel class of thrombin, inhibitors in the enzyme active site, based on the X-ray crystal structure, of compound 9 co-crystallized with human alpha-thrombin, is discussed.
The design, synthesis and biological activity of a series of novel non-covalent D-Phe-Pro-Arg motif-based thrombin inhibitors incorporating 4,5,6,7-tetrahydrobenzothiazol-2-amine as a novel arginine surrogate are described. Compound 9, the most potent in the series of thrombin inhibitors, exhibited an in vitro K(i) of 128 nM and 342-fold selectivity against trypsin. The binding mode of this novel class of thrombin inhibitors in the enzyme active site, based on the X-ray crystal structure of compound 9 co-crystallized with human alpha-thrombin, is discussed.


==Disease==
==Disease==
Line 11: Line 10:


==About this Structure==
==About this Structure==
1SB1 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with NA and 165 as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Thrombin Thrombin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.5 3.4.21.5] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1SB1 OCA].  
1SB1 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=NA:'>NA</scene> and <scene name='pdbligand=165:'>165</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Thrombin Thrombin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.5 3.4.21.5] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1SB1 OCA].  


==Reference==
==Reference==
Line 30: Line 29:
[[Category: thrombin; inhibition; hirugen; serine protease inhibitor]]
[[Category: thrombin; inhibition; hirugen; serine protease inhibitor]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 19:12:14 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:59:40 2008''